A New Means To Identify Type 3 Secreted Effectors: Functionally Interchangeable Class IB Chaperones Recognize a Conserved Sequence

por Costa, Sonia C. P., Schmitz, Alexa M., Jahufar, Fathima F., Boyd, Justin D., Cho, Min Y., Glicksman, Marcie A., Lesser, Cammie F.
Publicado 2012

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits

por Acosta-Alvear, Diego, Cho, Min Y, Wild, Thomas, Buchholz, Tonia J, Lerner, Alana G, Simakova, Olga, Hahn, Jamie, Korde, Neha, Landgren, Ola, Maric, Irina, Choudhary, Chunaram, Walter, Peter, Weissman, Jonathan S, Kampmann, Martin
Publicado 2015

Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent

por Jost, Marco, Chen, Yuwen, Gilbert, Luke A., Horlbeck, Max A., Krenning, Lenno, Menchon, Grégory, Rai, Ankit, Cho, Min Y., Stern, Jacob J., Prota, Andrea E., Kampmann, Martin, Akhmanova, Anna, Steinmetz, Michel O., Tanenbaum, Marvin E., Weissman, Jonathan S.
Publicado 2017

Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent

por Jost, Marco, Chen, Yuwen, Gilbert, Luke A., Horlbeck, Max A., Krenning, Lenno, Menchon, Grégory, Rai, Ankit, Cho, Min Y., Stern, Jacob J., Prota, Andrea E., Kampmann, Martin, Akhmanova, Anna, Steinmetz, Michel O., Tanenbaum, Marvin E., Weissman, Jonathan S.
Publicado 2020